SIWA Therapeutics
Pre-clinicalSIWA Therapeutics develops novel antibody therapies targeting senescent cells for age-related diseases.
Founded
2020
Focus
AntibodiesBiologics
About
SIWA Therapeutics develops novel antibody therapies targeting senescent cells for age-related diseases.
Funding History
2Total raised: $30M
Series A$25MBristol Myers SquibbNov 15, 2023
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile